GlassScriptPhysician profile
James J Bancroft
NPI 1417172917
$1,352.97
in general payments reported to CMS, 2019-2025
9 companies · $592 in 2025
The $592 reported for 2025 was more than what 83% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.17 · 2020: $191 · 2021: $60.46 · 2022: $55.17 · 2023: $127 · 2024: $289 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567 · Gift: $290 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.98 |
| Gift | $290.49 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $584.12 | 2019-2025 | Invisalign, Touch Up, Invisalign Touch Up |
| Ultradent Products INC | $290.49 | 2025 | Opalescence |
| Envista Holdings Corporation | $154.69 | 2024-2025 | Damon, Spark, Insignia |
| Ormco Corporation | $131.68 | 2021-2023 | Damon |
| Ortho Organizers, INC. | $74.25 | 2024 | Carriere, Carriere Slx 3d |
| American Orthodontics Corporation | $39.11 | 2023 | Empower-Metal, LP and Ifit Tubes, Radiance |
| USA Angelalign Technology Corp | $33.41 | 2025 | |
| Nobel Biocare USA | $31.05 | 2023 | Nobelactive |
| Dentsply Sirona INC | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bancroft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.